Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
01 08 2020
Historique:
pubmed: 24 4 2020
medline: 16 2 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

To provide evidence-based recommendations to practicing physicians and other health care providers on the diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck (SCCUP). The American Society of Clinical Oncology convened an Expert Panel of medical oncology, surgery, radiation oncology, radiology, pathology, and advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 2008 through 2019. Outcomes of interest included survival, local and regional disease control, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. The literature search identified 100 relevant studies to inform the evidence base for this guideline. Four main clinical questions were addressed, which included subquestions on preoperative evaluations, surgical diagnostic and therapeutic procedures, appropriate pathology techniques, and adjuvant therapy. Evidence-based recommendations were developed to address preoperative evaluation for patients with a neck mass, surgical diagnostic and therapeutic procedures, appropriate treatment options in unilateral versus bilateral SCCUP.Additional information is available at www.asco.org/head-neck-cancer-guidelines.

Identifiants

pubmed: 32324430
doi: 10.1200/JCO.20.00275
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2570-2596

Déclaration de conflit d'intérêts

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Auteurs

Ellie Maghami (E)

City of Hope, Duarte, CA.

Nofisat Ismaila (N)

American Society of Clinical Oncology, Alexandria, VA.

Adriana Alvarez (A)

Cleveland Clinic Foundation, Cleveland, OH.

Rebecca Chernock (R)

Washington University School of Medicine, St Louis, MO.

Umamaheswar Duvvuri (U)

University of Pittsburgh, Pittsburgh, PA.

Jessica Geiger (J)

Cleveland Clinic Foundation, Cleveland, OH.

Neil Gross (N)

MD Anderson Cancer Center, Houston, TX.

Bruce Haughey (B)

Advent Health Medical Group, Otolaryngology, Head and Neck Surgery, Celebration, FL, and University of South Florida, Tampa, FL.

Doru Paul (D)

Weill Cornell Medical College, New York, NY.

Cristina Rodriguez (C)

University of Washington, Seattle, WA.

David Sher (D)

University of Texas Southwestern, Dallas, TX.

Hilda E Stambuk (HE)

Memorial Sloan Kettering Cancer Center, New York, NY.

John Waldron (J)

Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Matt Witek (M)

University of Wisconsin School of Medicine and Public Health, Madison, WI.

James Caudell (J)

Moffitt Cancer Center, Tampa, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH